Skip to main content

Dr. David N. Barrera, DO

Medical Oncology (Medical Oncology Physician)

  • Medicare participating

At a glance

Years since graduation
33
In the NPI registry since
2006
Medicare patients seen, 2024
500

Licensed in Texas since 1994, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is

Education and training

  • 1993Medical school: University of North Texas Hsc, College of Osteopathic Med
  • 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier

Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Medical Oncology Physician primary
    TX license J6320 (first issued 1994; active)
  • Hematology & Oncology Physician
    TX license J6320 (first issued 1994; active)

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Medical Oncology per capita by county →

Where they work

Hospitals

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Medicare patients and services

Medicare patients, 2024
500
Services billed
81,342
Patients’ average age
76
Most frequent Medicare services, 2023
ServiceTimesPatients
Injection, iron sucrose, 1 mg14,30023
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml6,01064
Injection, pembrolizumab, 1 mg5,40011
Injection, denosumab, 1 mg96012
Injection, dexamethasone sodium phosphate, 1 mg94039
Insertion of needle into vein for collection of blood sample840345
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count806335
Blood test, comprehensive group of blood chemicals720319
Established patient office or other outpatient visit, 30-39 minutes611266
Injection, granisetron hydrochloride, 100 mcg36015

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Medicare prescriptions

Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.

Payments from drug and device companies

In 2025, 29 companies reported 80 payments worth $2,556 in total to this clinician.

By type
Food and Beverage$1,556
Long term medical supply or device loan$1,000

What the payments were for

Largest payments other than meals
DateCompanyWhat it was forAmount
Jan 23, 2025Novartis Pharmaceuticals Corporation
Jan 23, 2025
Long term medical supply or device loan
KISQALI · Oncology · in-kind
$83.33
Feb 21, 2025Novartis Pharmaceuticals Corporation
Feb 21, 2025
Long term medical supply or device loan
KISQALI · Oncology · in-kind
$83.33
Mar 26, 2025Novartis Pharmaceuticals Corporation
Mar 26, 2025
Long term medical supply or device loan
KISQALI · Oncology · in-kind
$83.33
May 15, 2025Novartis Pharmaceuticals Corporation
May 15, 2025
Long term medical supply or device loan
KISQALI · Oncology · in-kind
$83.33
Apr 24, 2025Novartis Pharmaceuticals Corporation
Apr 24, 2025
Long term medical supply or device loan
KISQALI · Oncology · in-kind
$83.33
Jun 12, 2025Novartis Pharmaceuticals Corporation
Jun 12, 2025
Long term medical supply or device loan
KISQALI · Oncology · in-kind
$83.33
Jul 25, 2025Novartis Pharmaceuticals Corporation
Jul 25, 2025
Long term medical supply or device loan
KISQALI · Oncology · in-kind
$83.33
Aug 21, 2025Novartis Pharmaceuticals Corporation
Aug 21, 2025
Long term medical supply or device loan
KISQALI · Oncology · in-kind
$83.33
Oct 23, 2025Novartis Pharmaceuticals Corporation
Oct 23, 2025
Long term medical supply or device loan
KISQALI · Oncology · in-kind
$83.33
Nov 26, 2025Novartis Pharmaceuticals Corporation
Nov 26, 2025
Long term medical supply or device loan
KISQALI · Oncology · in-kind
$83.33
All 12 payments other than meals, newest first
All payments other than meals
DateCompanyWhat it was forAmount
Dec 30, 2025Novartis Pharmaceuticals Corporation
Dec 30, 2025
Long term medical supply or device loan
KISQALI · Oncology · in-kind
$83.33
Nov 26, 2025Novartis Pharmaceuticals Corporation
Nov 26, 2025
Long term medical supply or device loan
KISQALI · Oncology · in-kind
$83.33
Oct 23, 2025Novartis Pharmaceuticals Corporation
Oct 23, 2025
Long term medical supply or device loan
KISQALI · Oncology · in-kind
$83.33
Sep 19, 2025Novartis Pharmaceuticals Corporation
Sep 19, 2025
Long term medical supply or device loan
KISQALI · Oncology · in-kind
$83.33
Aug 21, 2025Novartis Pharmaceuticals Corporation
Aug 21, 2025
Long term medical supply or device loan
KISQALI · Oncology · in-kind
$83.33
Jul 25, 2025Novartis Pharmaceuticals Corporation
Jul 25, 2025
Long term medical supply or device loan
KISQALI · Oncology · in-kind
$83.33
Jun 12, 2025Novartis Pharmaceuticals Corporation
Jun 12, 2025
Long term medical supply or device loan
KISQALI · Oncology · in-kind
$83.33
May 15, 2025Novartis Pharmaceuticals Corporation
May 15, 2025
Long term medical supply or device loan
KISQALI · Oncology · in-kind
$83.33
Apr 24, 2025Novartis Pharmaceuticals Corporation
Apr 24, 2025
Long term medical supply or device loan
KISQALI · Oncology · in-kind
$83.33
Mar 26, 2025Novartis Pharmaceuticals Corporation
Mar 26, 2025
Long term medical supply or device loan
KISQALI · Oncology · in-kind
$83.33
Feb 21, 2025Novartis Pharmaceuticals Corporation
Feb 21, 2025
Long term medical supply or device loan
KISQALI · Oncology · in-kind
$83.33
Jan 23, 2025Novartis Pharmaceuticals Corporation
Jan 23, 2025
Long term medical supply or device loan
KISQALI · Oncology · in-kind
$83.33

Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in Texas →

Other Medical Oncology clinicians in Fort Worth

Sources

NPI registry (CMS NPPES, November 2026; record last updated February 9, 2024), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1063444297. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.